The close of Mylan's deal to acquire Meda marks the beginning of another exciting chapter as we work to create better health for a better world.
Mylan acquires Abbott's non-U.S developed market specialty and branded generics business.
See inside our passion, innovation and commitment.
Innovation is a part of who we are and the reason we see opportunity in every challenge.
Discover why we’re one of the world’s leading generics and specialty pharmaceutical companies.
See how we manufacture some of the highest quality generic and specialty pharmaceuticals in the world.